RARE
Ultragenyx Pharmaceutical Inc
$21.71
-2.25% ($0.50)
Volume
1.46M
52W High
$42.37
52W Low
$18.41
Market Cap
$2.30B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$1.34
Whisper EPS
-$1.34
0.0% above consensus
Last Quarter
-$1.29
Current Streak
2 Misss
Avg Surprise (4Q)
-16.80%
Next Earnings Report
Reports in 47 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Feb 12, 2026
1-Day:
-12.68%
5-Day:
-14.13%
Q3 2025
Nov 6, 2025
1-Day:
-1.03%
5-Day:
+7.43%
Q2 2025
Aug 5, 2025
1-Day:
-3.01%
Q1 2025
May 6, 2025
1-Day:
-4.68%
Revenue & Financial Performance
Revenue Whisper
$187.0M
TWN Proprietary Estimate
Last Quarter Revenue
$207.0M
+25.6% YoY
Gross Margin
86.0%
Net Margin: -62.3%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $207.0M | +25.6% | 86.0% | -55.1% | -$129.0M |
| Q3'25 | $159.9M | +14.7% | 82.5% | -106.9% | -$180.4M |
| Q2'25 | $166.5M | +13.2% | 86.2% | -64.8% | -$115.0M |
| Q1'25 | $139.3M | +28.0% | 79.4% | -102.6% | -$151.1M |
| Q4'24 | $164.9M | +29.4% | 89.8% | -74.2% | -$133.4M |
| Q3'24 | $139.5M | +42.3% | 84.9% | -94.6% | -$133.5M |
| Q2'24 | $147.0M | +35.8% | 85.5% | -79.1% | -$131.6M |
| Q1'24 | $108.8M | +8.3% | 83.9% | -151.9% | -$170.7M |
Company Information
Symbol
RARE
Company
Ultragenyx Pharmaceutical Inc
Market Cap
$2.30B
Next Earnings
Apr 30, 2026